Type |
Details |
Score |
Gene |
Type: |
gene |
Organism: |
human |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
frog, western clawed |
|
•
•
•
•
•
|
Gene |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
dog, domestic |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
chimpanzee |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
cattle |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
chicken |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
macaque, rhesus |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
ATP-binding cassette subfamily G member 2 (ABCG2) is a eukaryotic member of the ABC transporter family. In humans, ABCG2 is a high-capacity urate exporter, functioning in both renal and extrarenal urate excretion []. It is a major factor contributing to gout [, ]. It also coordinates with another transporter, ABCB6, to modulate porphyrin concentrations under normal physiological and pathological conditions []. In addition, it can function as a xenobiotic transporter and may play a major role in multi-drug resistance []. The ABC transporter family is a group of membrane proteins that use the hydrolysis of ATP to power the translocation of a wide variety of substrates across cellular membranes. ABC transporters minimally consist of two conserved regions: a highly conserved nucleotide-binding domain (NBD) and a less conserved transmembrane domain (TMD). Eukaryotic ABC proteins are usually organised either as full transporters (containing two NBDs and two TMDs), or as half transporters (containing one NBD and one TMD), that have to form homo- or heterodimers in order to constitute a functional protein []. |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
159
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
115
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
172
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
657
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
576
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
623
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
657
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Takada T |
Year: |
2018 |
Journal: |
Sci Rep |
Title: |
Identification of ABCG2 as an Exporter of Uremic Toxin Indoxyl Sulfate in Mice and as a Crucial Factor Influencing CKD Progression. |
Volume: |
8 |
Issue: |
1 |
Pages: |
11147 |
|
•
•
•
•
•
|
Publication |
First Author: |
Santamarina-Fojo S |
Year: |
2006 |
Journal: |
MGI Direct Data Submission |
Title: |
Generation of a conditional Abcg2 allele |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Chang HM |
Year: |
2016 |
Journal: |
Exp Dermatol |
Title: |
ABCG2 deficiency in skin impairs re-epithelialization in cutaneous wound healing. |
Volume: |
25 |
Issue: |
5 |
Pages: |
355-61 |
|
•
•
•
•
•
|
Publication |
First Author: |
Krishnamurthy P |
Year: |
2011 |
Journal: |
Curr Pharm Biotechnol |
Title: |
The role of ABCG2 and ABCB6 in porphyrin metabolism and cell survival. |
Volume: |
12 |
Issue: |
4 |
Pages: |
647-55 |
|
•
•
•
•
•
|
Publication |
First Author: |
Matsuo H |
Year: |
2011 |
Journal: |
Nucleosides Nucleotides Nucleic Acids |
Title: |
Identification of ABCG2 dysfunction as a major factor contributing to gout. |
Volume: |
30 |
Issue: |
12 |
Pages: |
1098-104 |
|
•
•
•
•
•
|
Publication |
First Author: |
Nakayama A |
Year: |
2011 |
Journal: |
Nucleosides Nucleotides Nucleic Acids |
Title: |
ABCG2 is a high-capacity urate transporter and its genetic impairment increases serum uric acid levels in humans. |
Volume: |
30 |
Issue: |
12 |
Pages: |
1091-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Garcia-Lino AM |
Year: |
2020 |
Journal: |
Biochem Pharmacol |
Title: |
Abcg2 transporter affects plasma, milk and tissue levels of meloxicam. |
Volume: |
175 |
|
Pages: |
113924 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kubota M |
Year: |
2010 |
Journal: |
Invest Ophthalmol Vis Sci |
Title: |
The anti-oxidative role of ABCG2 in corneal epithelial cells. |
Volume: |
51 |
Issue: |
11 |
Pages: |
5617-22 |
|
•
•
•
•
•
|
Publication |
First Author: |
van de Wetering K |
Year: |
2012 |
Journal: |
FASEB J |
Title: |
ABCG2 functions as a general phytoestrogen sulfate transporter in vivo. |
Volume: |
26 |
Issue: |
10 |
Pages: |
4014-24 |
|
•
•
•
•
•
|
Publication |
First Author: |
Morfouace M |
Year: |
2015 |
Journal: |
Cancer Res |
Title: |
ABCG2 Transporter Expression Impacts Group 3 Medulloblastoma Response to Chemotherapy. |
Volume: |
75 |
Issue: |
18 |
Pages: |
3879-89 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fatima S |
Year: |
2012 |
Journal: |
Stem Cells |
Title: |
Abcg2 expression marks tissue-specific stem cells in multiple organs in a mouse progeny tracking model. |
Volume: |
30 |
Issue: |
2 |
Pages: |
210-21 |
|
•
•
•
•
•
|
Publication |
First Author: |
Maher TJ |
Year: |
2014 |
Journal: |
Am J Physiol Heart Circ Physiol |
Title: |
ATP-binding cassette transporter Abcg2 lineage contributes to the cardiac vasculature after oxidative stress. |
Volume: |
306 |
Issue: |
12 |
Pages: |
H1610-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zeng Y |
Year: |
2012 |
Journal: |
J Neurochem |
Title: |
Abcg2 deficiency augments oxidative stress and cognitive deficits in Tg-SwDI transgenic mice. |
Volume: |
122 |
Issue: |
2 |
Pages: |
456-69 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hoque KM |
Year: |
2020 |
Journal: |
Nat Commun |
Title: |
The ABCG2 Q141K hyperuricemia and gout associated variant illuminates the physiology of human urate excretion. |
Volume: |
11 |
Issue: |
1 |
Pages: |
2767 |
|
•
•
•
•
•
|
Publication |
First Author: |
Scharenberg C |
Year: |
2009 |
Journal: |
Biochem Biophys Res Commun |
Title: |
ABCG2 is expressed in late spermatogenesis and is associated with the acrosome. |
Volume: |
378 |
Issue: |
2 |
Pages: |
302-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wang P |
Year: |
2019 |
Journal: |
Sci Adv |
Title: |
The essential role of the transporter ABCG2 in the pathophysiology of erythropoietic protoporphyria. |
Volume: |
5 |
Issue: |
9 |
Pages: |
eaaw6127 |
|
•
•
•
•
•
|
Publication |
First Author: |
Nagy BM |
Year: |
2017 |
Journal: |
Front Physiol |
Title: |
Lack of ABCG2 Leads to Biventricular Dysfunction and Remodeling in Response to Hypoxia. |
Volume: |
8 |
|
Pages: |
98 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wu AM |
Year: |
2014 |
Journal: |
Am J Physiol Endocrinol Metab |
Title: |
Role of STAT5 and epigenetics in lactation-associated upregulation of multidrug transporter ABCG2 in the mammary gland. |
Volume: |
307 |
Issue: |
7 |
Pages: |
E596-610 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhang P |
Year: |
2015 |
Journal: |
Int J Cancer |
Title: |
ABCB1 and ABCG2 restrict the brain penetration of a panel of novel EZH2-Inhibitors. |
Volume: |
137 |
Issue: |
8 |
Pages: |
2007-18 |
|
•
•
•
•
•
|
Publication |
First Author: |
Cisternino S |
Year: |
2004 |
Journal: |
Cancer Res |
Title: |
Expression, up-regulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrier. |
Volume: |
64 |
Issue: |
9 |
Pages: |
3296-301 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhou S |
Year: |
2005 |
Journal: |
Blood |
Title: |
Increased expression of the Abcg2 transporter during erythroid maturation plays a role in decreasing cellular protoporphyrin IX levels. |
Volume: |
105 |
Issue: |
6 |
Pages: |
2571-6 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zong Y |
Year: |
2006 |
Journal: |
J Biol Chem |
Title: |
Expression of mouse Abcg2 mRNA during hematopoiesis is regulated by alternative use of multiple leader exons and promoters. |
Volume: |
281 |
Issue: |
40 |
Pages: |
29625-32 |
|
•
•
•
•
•
|
Publication |
First Author: |
Matsuo H |
Year: |
2011 |
Journal: |
Nucleosides Nucleotides Nucleic Acids |
Title: |
ABCG2/BCRP dysfunction as a major cause of gout. |
Volume: |
30 |
Issue: |
12 |
Pages: |
1117-28 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bruhn O |
Year: |
2014 |
Journal: |
Expert Opin Drug Metab Toxicol |
Title: |
Polymorphisms of the drug transporters ABCB1, ABCG2, ABCC2 and ABCC3 and their impact on drug bioavailability and clinical relevance. |
Volume: |
10 |
Issue: |
10 |
Pages: |
1337-54 |
|
•
•
•
•
•
|
Publication |
First Author: |
Traxl A |
Year: |
2017 |
Journal: |
Drug Metab Dispos |
Title: |
Hepatocyte-Specific Deletion of EGFR in Mice Reduces Hepatic Abcg2 Transport Activity Measured by [11C]erlotinib and Positron Emission Tomography. |
Volume: |
45 |
Issue: |
10 |
Pages: |
1093-1100 |
|
•
•
•
•
•
|
Publication |
First Author: |
Pfister O |
Year: |
2008 |
Journal: |
Circ Res |
Title: |
Role of the ATP-binding cassette transporter Abcg2 in the phenotype and function of cardiac side population cells. |
Volume: |
103 |
Issue: |
8 |
Pages: |
825-35 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wang Y |
Year: |
2020 |
Journal: |
Br J Pharmacol |
Title: |
OATP1A/1B, CYP3A, ABCB1, and ABCG2 limit oral availability of the NTRK inhibitor larotrectinib, while ABCB1 and ABCG2 also restrict its brain accumulation. |
Volume: |
177 |
Issue: |
13 |
Pages: |
3060-3074 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
168
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Zander SA |
Year: |
2012 |
Journal: |
Cancer Prev Res (Phila) |
Title: |
Lack of ABCG2 shortens latency of BRCA1-deficient mammary tumors and this is not affected by genistein or resveratrol. |
Volume: |
5 |
Issue: |
8 |
Pages: |
1053-60 |
|
•
•
•
•
•
|
Publication |
First Author: |
Higashikuni Y |
Year: |
2012 |
Journal: |
Arterioscler Thromb Vasc Biol |
Title: |
The ATP-binding cassette transporter ABCG2 protects against pressure overload-induced cardiac hypertrophy and heart failure by promoting angiogenesis and antioxidant response. |
Volume: |
32 |
Issue: |
3 |
Pages: |
654-61 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gewin LS |
Year: |
2019 |
Journal: |
Am J Physiol Renal Physiol |
Title: |
Inactivation of Tsc2 in Abcg2 lineage-derived cells drives the appearance of polycystic lesions and fibrosis in the adult kidney. |
Volume: |
317 |
Issue: |
5 |
Pages: |
F1201-F1210 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
130
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Dean M |
Year: |
2001 |
Journal: |
J Lipid Res |
Title: |
The human ATP-binding cassette (ABC) transporter superfamily. |
Volume: |
42 |
Issue: |
7 |
Pages: |
1007-17 |
|
•
•
•
•
•
|
Publication |
First Author: |
Garcia-Mateos D |
Year: |
2019 |
Journal: |
Drug Metab Dispos |
Title: |
Role of ABCG2 in Secretion into Milk of the Anti-Inflammatory Flunixin and Its Main Metabolite: In Vitro-In Vivo Correlation in Mice and Cows. |
Volume: |
47 |
Issue: |
5 |
Pages: |
516-524 |
|
•
•
•
•
•
|
Publication |
First Author: |
Allen JD |
Year: |
1999 |
Journal: |
Cancer Res |
Title: |
The mouse Bcrp1/Mxr/Abcp gene: amplification and overexpression in cell lines selected for resistance to topotecan, mitoxantrone, or doxorubicin. |
Volume: |
59 |
Issue: |
17 |
Pages: |
4237-41 |
|
•
•
•
•
•
|
Publication |
First Author: |
Allikmets R |
Year: |
1998 |
Journal: |
Cancer Res |
Title: |
A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. |
Volume: |
58 |
Issue: |
23 |
Pages: |
5337-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Jonker JW |
Year: |
2002 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria. |
Volume: |
99 |
Issue: |
24 |
Pages: |
15649-54 |
|
•
•
•
•
•
|
Publication |
First Author: |
van Herwaarden AE |
Year: |
2007 |
Journal: |
Mol Cell Biol |
Title: |
Multidrug transporter ABCG2/breast cancer resistance protein secretes riboflavin (vitamin B2) into milk. |
Volume: |
27 |
Issue: |
4 |
Pages: |
1247-53 |
|
•
•
•
•
•
|
Publication |
First Author: |
Xie Y |
Year: |
2013 |
Journal: |
Biochim Biophys Acta |
Title: |
Bcrp1 transcription in mouse testis is controlled by a promoter upstream of a novel first exon (E1U) regulated by steroidogenic factor-1. |
Volume: |
1829 |
Issue: |
12 |
Pages: |
1288-99 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lin YH |
Year: |
2013 |
Journal: |
FEBS Lett |
Title: |
Protoporphyrin IX accumulation disrupts mitochondrial dynamics and function in ABCG2-deficient hepatocytes. |
Volume: |
587 |
Issue: |
19 |
Pages: |
3202-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Marriott S |
Year: |
2014 |
Journal: |
Am J Physiol Cell Physiol |
Title: |
ABCG2pos lung mesenchymal stem cells are a novel pericyte subpopulation that contributes to fibrotic remodeling. |
Volume: |
307 |
Issue: |
8 |
Pages: |
C684-98 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chow K |
Year: |
2013 |
Journal: |
Pulm Circ |
Title: |
Dysfunctional resident lung mesenchymal stem cells contribute to pulmonary microvascular remodeling. |
Volume: |
3 |
Issue: |
1 |
Pages: |
31-49 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gaskill CF |
Year: |
2017 |
Journal: |
J Clin Invest |
Title: |
Disruption of lineage specification in adult pulmonary mesenchymal progenitor cells promotes microvascular dysfunction. |
Volume: |
127 |
Issue: |
6 |
Pages: |
2262-2276 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ichida K |
Year: |
2012 |
Journal: |
Nat Commun |
Title: |
Decreased extra-renal urate excretion is a common cause of hyperuricemia. |
Volume: |
3 |
|
Pages: |
764 |
|
•
•
•
•
•
|
Publication |
First Author: |
Karibe T |
Year: |
2015 |
Journal: |
Pharm Res |
Title: |
Evaluation of the usefulness of breast cancer resistance protein (BCRP) knockout mice and BCRP inhibitor-treated monkeys to estimate the clinical impact of BCRP modulation on the pharmacokinetics of BCRP substrates. |
Volume: |
32 |
Issue: |
5 |
Pages: |
1634-47 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sereti KI |
Year: |
2013 |
Journal: |
Circ Res |
Title: |
ATP-binding cassette G-subfamily transporter 2 regulates cell cycle progression and asymmetric division in mouse cardiac side population progenitor cells. |
Volume: |
112 |
Issue: |
1 |
Pages: |
27-34 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tadjali M |
Year: |
2006 |
Journal: |
Stem Cells |
Title: |
Prospective isolation of murine hematopoietic stem cells by expression of an Abcg2/GFP allele. |
Volume: |
24 |
Issue: |
6 |
Pages: |
1556-63 |
|
•
•
•
•
•
|
Publication |
First Author: |
Petropoulos S |
Year: |
2011 |
Journal: |
Biol Reprod |
Title: |
Breast cancer-resistance protein (BCRP1) in the fetal mouse brain: development and glucocorticoid regulation. |
Volume: |
84 |
Issue: |
4 |
Pages: |
783-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tang SC |
Year: |
2012 |
Journal: |
Int J Cancer |
Title: |
Brain accumulation of sunitinib is restricted by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and can be enhanced by oral elacridar and sunitinib coadministration. |
Volume: |
130 |
Issue: |
1 |
Pages: |
223-33 |
|
•
•
•
•
•
|
Publication |
First Author: |
Takenaka K |
Year: |
2007 |
Journal: |
Cancer Res |
Title: |
Substrate overlap between Mrp4 and Abcg2/Bcrp affects purine analogue drug cytotoxicity and tissue distribution. |
Volume: |
67 |
Issue: |
14 |
Pages: |
6965-72 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lin F |
Year: |
2013 |
Journal: |
Int J Cancer |
Title: |
Dual mTORC1 and mTORC2 inhibitor Palomid 529 penetrates the blood-brain barrier without restriction by ABCB1 and ABCG2. |
Volume: |
133 |
Issue: |
5 |
Pages: |
1222-33 |
|
•
•
•
•
•
|
Publication |
First Author: |
Summers ME |
Year: |
2020 |
Journal: |
FASEB J |
Title: |
Resident mesenchymal vascular progenitors modulate adaptive angiogenesis and pulmonary remodeling via regulation of canonical Wnt signaling. |
Volume: |
34 |
Issue: |
8 |
Pages: |
10267-10285 |
|
•
•
•
•
•
|
Publication |
First Author: |
Martin CM |
Year: |
2004 |
Journal: |
Dev Biol |
Title: |
Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart. |
Volume: |
265 |
Issue: |
1 |
Pages: |
262-75 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tang SC |
Year: |
2014 |
Journal: |
Int J Cancer |
Title: |
Increased oral availability and brain accumulation of the ALK inhibitor crizotinib by coadministration of the P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) inhibitor elacridar. |
Volume: |
134 |
Issue: |
6 |
Pages: |
1484-94 |
|
•
•
•
•
•
|
Publication |
First Author: |
Spiro AS |
Year: |
2012 |
Journal: |
PLoS One |
Title: |
Enhanced brain disposition and effects of Δ9-tetrahydrocannabinol in P-glycoprotein and breast cancer resistance protein knockout mice. |
Volume: |
7 |
Issue: |
4 |
Pages: |
e35937 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hoque MT |
Year: |
2015 |
Journal: |
J Neurochem |
Title: |
In vivo and ex vivo regulation of breast cancer resistant protein (Bcrp) by peroxisome proliferator-activated receptor alpha (Pparα) at the blood-brain barrier. |
Volume: |
135 |
Issue: |
6 |
Pages: |
1113-22 |
|
•
•
•
•
•
|
Publication |
First Author: |
de Wolf CJ |
Year: |
2007 |
Journal: |
FEBS J |
Title: |
cGMP transport by vesicles from human and mouse erythrocytes. |
Volume: |
274 |
Issue: |
2 |
Pages: |
439-50 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hamdan AM |
Year: |
2012 |
Journal: |
J Biol Chem |
Title: |
Intestinal expression of mouse Abcg2/breast cancer resistance protein (BCRP) gene is under control of circadian clock-activating transcription factor-4 pathway. |
Volume: |
287 |
Issue: |
21 |
Pages: |
17224-31 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zander SA |
Year: |
2010 |
Journal: |
Cancer Res |
Title: |
Sensitivity and acquired resistance of BRCA1;p53-deficient mouse mammary tumors to the topoisomerase I inhibitor topotecan. |
Volume: |
70 |
Issue: |
4 |
Pages: |
1700-10 |
|
•
•
•
•
•
|
Publication |
First Author: |
Schumacher T |
Year: |
2012 |
Journal: |
PLoS One |
Title: |
ABC transporters B1, C1 and G2 differentially regulate neuroregeneration in mice. |
Volume: |
7 |
Issue: |
4 |
Pages: |
e35613 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ristic B |
Year: |
2020 |
Journal: |
Biochem J |
Title: |
Hereditary hemochromatosis disrupts uric acid homeostasis and causes hyperuricemia via altered expression/activity of xanthine oxidase and ABCG2. |
Volume: |
477 |
Issue: |
8 |
Pages: |
1499-1513 |
|
•
•
•
•
•
|
Publication |
First Author: |
Li L |
Year: |
2011 |
Journal: |
Gene Expr Patterns |
Title: |
Expression patterns of ABCG2, Bmi-1, Oct-3/4, and Yap in the developing mouse incisor. |
Volume: |
11 |
Issue: |
3-4 |
Pages: |
163-70 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lin F |
Year: |
2014 |
Journal: |
Clin Cancer Res |
Title: |
ABCB1, ABCG2, and PTEN determine the response of glioblastoma to temozolomide and ABT-888 therapy. |
Volume: |
20 |
Issue: |
10 |
Pages: |
2703-13 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sawicki WT |
Year: |
2006 |
Journal: |
Gene Expr Patterns |
Title: |
Temporal/spatial expression and efflux activity of ABC transporter, P-glycoprotein/Abcb1 isoforms and Bcrp/Abcg2 during early murine development. |
Volume: |
6 |
Issue: |
7 |
Pages: |
738-46 |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
Mus caroli |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
Mus pahari |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
Mus spretus |
|
•
•
•
•
•
|
Publication |
First Author: |
Jonker JW |
Year: |
2007 |
Journal: |
Am J Physiol Cell Physiol |
Title: |
Breast cancer resistance protein (Bcrp1/Abcg2) is expressed in the harderian gland and mediates transport of conjugated protoporphyrin IX. |
Volume: |
292 |
Issue: |
6 |
Pages: |
C2204-12 |
|
•
•
•
•
•
|
Publication |
First Author: |
Higashikuni Y |
Year: |
2010 |
Journal: |
Arterioscler Thromb Vasc Biol |
Title: |
The ATP-binding cassette transporter BCRP1/ABCG2 plays a pivotal role in cardiac repair after myocardial infarction via modulation of microvascular endothelial cell survival and function. |
Volume: |
30 |
Issue: |
11 |
Pages: |
2128-35 |
|
•
•
•
•
•
|